EF
Emily Field Barclays Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
9
Avg Return
Past Year
Past Year
2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
44.4%
Neutral
44.4%
Negative
11.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Underweight
Initiated
| $25 |
4%
downside
| 1 | +0.67% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Overweight
Initiated
| $140 |
22%
upside
| 1 | -5.1% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Equal-Weight
Initiated
| $155 |
22%
upside
| 1 | – |
–
| 20 Feb ‘26 3 months ago |
|
|
|
Overweight
Initiated
| $1,350 |
20%
upside
| 1 | -3.2% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Overweight
Initiated
| $75 |
34%
upside
| 1 | -1.2% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Equal-Weight
Initiated
| $185 |
6%
downside
| 1 | – |
–
| 20 Feb ‘26 3 months ago |
|
|
|
Equal-Weight
Initiated
| $350 |
0%
upside
| 1 | – |
–
| 20 Feb ‘26 3 months ago |
|
|
|
Overweight
Initiated
| $275 |
25%
upside
| 1 | -1.1% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Equal-Weight
Downgraded
| – | – | 1 | – |
–
| 30 Jul ‘25 10 months ago |
|